ArticleAnnals of medicine and surgery (2012)2026
Efficacy of intravascular ultrasound-guided primary percutaneous coronary intervention in acute coronary syndrome: a meta-analysis of randomized controlled trials with meta-regression.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute coronary syndrome (ACS) is effectively managed with primary percutaneous coronary intervention (PCI), enhanced by intravascular ultrasound (IVUS) for precise stent placement. This meta-analysis evaluates the efficacy and safety of IVUS-guided PCI compared to non-IVUS-guided PCI (e.g., angiography or optical coherence tomography) in ACS patients. Methods: Following PRISMA guidelines, we searched PubMed, Embase, Cochrane CENTRAL, and ClinicalTrials.gov for randomized controlled trials (RCTs) from January 2014 to August 2024 comparing IVUS-guided PCI with non-IVUS-guided PCI in ACS patients. Nine RCTs involving 11 843 patients (6230 IVUS and 5613 non-IVUS) were included. Outcomes included target lesion revascularization (TLR), target vessel failure (TVF), post-procedural myocardial infarction (MI), stent thrombosis, major adverse cardiac events (MACE), and all-cause mortality. Data were pooled using a random-effects model, with risk ratios (RRs) and 95% confidence intervals (CIs) calculated. Heterogeneity was assessed via Results: IVUS-guided PCI significantly reduced TLR (RR 0.62, 95% CI 0.48-0.80, Conclusion: IVUS-guided PCI significantly lowers risks of TLR, TVF, and post-procedural MI in ACS patients, with a trend toward reduced MACE, supporting its use for improved PCI outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.